Descripción del título
Monografía
monografia Rebiun36102118 https://catalogo.rebiun.org/rebiun/record/Rebiun36102118 m o d f cr mnu|||uuaun 100201s1998 mdua ob f000 0 eng d 56351711 649985518 692575150 809472904 1042547017 017-024-01626-8 GPO WUM eng pn WUM BUF OCLCE OCLCQ OCLCA OCLCF OCLCO OCLCA OCLCQ OCLCO INARC OCLCA IAK OCLCQ OCLCO OCL OCLCQ OCLCO OCLCL OCLCQ n-us--- National Institute on Drug Abuse Cost-benefit/cost-effectiveness research of drug abuse prevention implications for programming and policy editors, William J. Bukoski, Richard I. Evans Rockville, MD U.S. Dept. of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, Division of Epidemiology and Prevention Research 1998 Rockville, MD Rockville, MD U.S. Dept. of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, Division of Epidemiology and Prevention Research 1 online resource (iv, 233 pages) illustrations 1 online resource (iv, 233 pages) Text txt rdacontent computer c rdamedia online resource cr rdacarrier NIDA research monograph 176 NIH publication no. 98-4021 "Based on the papers from a technical review ... held on July 28-29, 1994"--Page ii Includes bibliographical references Impact of substance abuse on federal spending -- Historical perspective on effective prevention -- School-based approaches to drug abuse prevention: evidence for effectiveness and suggestions for determining cost-effectiveness -- Effectiveness of prevention interventions with youth at high risk of drug abuse -- Costs, benefits, and cost-effectiveness of comprehensive drug abuse prevention -- Overview of methods: cost-effectiveness, cost-benefits, and cost-offsets of prevention -- Analytic issues for estimating the benefits and costs of substance abuse prevention -- Benefits and costs of a family-focused methadone treatment and drug abuse prevention program: preliminary findings -- Issues and methods in evaluating costs, benefits, and cost-effectiveness of drug abuse prevention programs for high-risk youth -- Implications for prevention policy: a commentary Use copy. Restrictions unspecified. MiAaHDL star Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002. http://purl.oclc.org/DLF/benchrepro0212 MiAaHDL digitized 2010 HathiTrust Digital Library committed to preserve MiAaHDL pda Drug abuse- United States- Prevention- Finance Cost effectiveness Substance-Related Disorders- prevention & control Substance-Related Disorders- economics Cost-Benefit Analysis Toxicomanie- États-Unis- Prévention- Finances Coût-efficacité cost benefit analysis. Cost effectiveness. Drug abuse- Prevention- Finance. Estados Unidos Estados Unidos https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq Online book Bukoski, William J. Evans, Richard I. Richard Isadore),) 1922-2015.) https://id.oclc.org/worldcat/entity/E39PBJkT8hWGrg8bdhgr6h89jC National Institute on Drug Abuse. Division of Epidemiology and Prevention Research Print version National Institute on Drug Abuse. Cost-benefit/cost-effectiveness research of drug abuse prevention. Rockville, MD : U.S. Dept. of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, Division of Epidemiology and Prevention Research, 1998 (DLC) 98186785 (OCoLC)40216284 NIDA research monograph 176 NIH publication no. 98-4021